Beth Beaudet
Impact in
- Epidemiology top 10%
- Trypanosoma species research and implications
Papers in
-
- Trypanosoma species research and implications 4
-
- Drug Solubulity and Delivery Systems 1
- Co-authors
- Ryan Randolph (1 shared paper)Diane M. Ignar (1 shared paper)Cindy Rewerts (1 shared paper)Jason D. Speake (1 shared paper)Cyrus J. Bacchi (1 shared paper)Luke Mercer (1 shared paper)Zhiyang Zhao (1 shared paper)Melanie N. Tallman (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (1 paper)Parasitology (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Pharmaceutical Research (1 paper)PLoS neglected tropical diseases (1 paper)
- Partner nations
- United StatesSwitzerland
In The Last Decade
Beth Beaudet
6 papers receiving 379 citations
Peers
Comparison fields: 5 of 46
- Epidemiology 217
- Parasitology 14
- Organic Chemistry 52
- Computational Theory and Mathematics 25
- Cancer Research 16
Countries citing papers authored by Beth Beaudet
This map shows the geographic impact of Beth Beaudet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth Beaudet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth Beaudet more than expected).
Fields of papers citing papers by Beth Beaudet
This network shows the impact of papers produced by Beth Beaudet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth Beaudet. The network helps show where Beth Beaudet may publish in the future.
Co-authors
The 17 scholars most cited alongside Beth Beaudet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 239 | |
| 2 | 2010 | 82 | |
| 3 | 2001 | 34 | |
| 4 | 2013 | 28 | |
| 5 | 2007 | 14 | |
| 6 | Efficacy and Pharmacokinetics of SCYX-7158 (AN5568): a Novel and Potent Oxaborole-6-Carboxamide Selected as a Pre-Clinical Candidate for Once-Daily Oral Treatment for Stage 2 Human African Trypanosomiasis. | 2009 | 1 |
About Beth Beaudet
Beth Beaudet is a scholar working on Epidemiology, Pharmaceutical Science, Pharmacology, Rheumatology and Oncology, having authored 6 papers that have together received 398 indexed citations. Recurring topics across this work include Trypanosoma species research and implications (4 papers), Drug Solubulity and Delivery Systems (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Drug Transport and Resistance Mechanisms (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Epidemiology (217 citations), Parasitology (14 citations), Organic Chemistry (52 citations), Computational Theory and Mathematics (25 citations) and Cancer Research (16 citations). Beth Beaudet has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Ryan Randolph, Diane M. Ignar, Cindy Rewerts, Jason D. Speake, Cyrus J. Bacchi, Luke Mercer, Zhiyang Zhao, Melanie N. Tallman, Jeffrey P. Krise and Eric Gaukel. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Parasitology, Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research and PLoS neglected tropical diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.